Cargando…
Blood glucose levels and bodyweight change after dapagliflozin administration
AIMS/INTRODUCTION: Increased blood glucose or increased weight is often observed in patients who are prescribed sodium–glucose cotransporter 2 inhibitors (SGLT2i). The aim of this study was to determine in advance which patients, among those prescribed a SGLT2i, would be likely to have improved or w...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409884/ https://www.ncbi.nlm.nih.gov/pubmed/33522718 http://dx.doi.org/10.1111/jdi.13516 |